5 Stocks To Watch For December 23, 2020

Some of the stocks that may grab investor focus today are:

Pfizer Inc PFE is nearing a deal with President Donald Trump's administration to supply 100 million doses of its Covid-19 vaccine to the US, the Wall Street Journal reported. Pfizer shares gained 0.2% to $36.82 in the after-hours trading session.
Wall Street expects Paychex, Inc. PAYX to report quarterly earnings at $0.66 per share on revenue of $953.97 million before the opening bell. Paychex shares rose 0.1% to close at $96.63 on Tuesday.
AstraZeneca Plc AZN and Russia have agreed to test a combination of their vaccines. The company signed a memorandum of cooperation with the Gamaleya Institute, the Russian Direct Investment Fund, and Russia-based pharmaceutical firm R-Pharm to study the combination. AstraZeneca and Amgen, on Tuesday, announced the SOURCE Phase 3 trial did not meet the primary endpoint of a statistically significant reduction in the daily oral corticosteroid dose, without loss of asthma control, with tezepelumab compared to placebo. AstraZeneca shares slipped 0.3% to $48.60 in the after-hours trading session.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Martin Midstream Partners L.P. MMLP reported the sale of Mega Lubricants to John W. Stone Oil for $22.4 million. Martin Midstream Partners shares rose 1.8% to $1.66 in the after-hours trading session.
Supernus Pharmaceuticals Inc SUPN reported that SPN-812 exhibited positive topline results in its Phase III study for the treatment of attention deficit hyperactivity disorder. Supernus Pharmaceuticals shares jumped 24.3% to $27.99 in after-hours trading.

Earnings Calendar